Sick patients who got plasma transfusions from those who had recovered from the coronavirus infection had better survival rates compared with a control group
Researchers at Icahn School of Medicine at Mount Sinai and the Johns Hopkins Bloomberg School of Public Health found the patients who received convalescent plasma had better outcomes compared with similar patients who didn’t get the transfusions. In the study, the plasma recipients were more likely to remain stable or show improvement in their requirements for supplemental oxygen. They also had improved survival when compared to the control patients.